Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $19,661 | 6 | 80.4% |
| Food and Beverage | $4,784 | 147 | 19.6% |
| Honoraria | $16.40 | 2 | 0.1% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $19,661 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,311 | 35 | $0 (2024) |
| Alimera Sciences, Inc. | $948.71 | 22 | $0 (2024) |
| Genentech USA, Inc. | $735.41 | 29 | $0 (2024) |
| Allergan, Inc. | $626.55 | 24 | $0 (2021) |
| Astellas Pharma US Inc | $336.06 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $171.80 | 7 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $164.29 | 6 | $0 (2024) |
| ABBVIE INC. | $150.03 | 7 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $109.81 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,776 | 41 | Alimera Sciences, Inc. ($559.36) |
| 2023 | $1,046 | 36 | Genentech USA, Inc. ($387.17) |
| 2022 | $8,938 | 21 | US Retina LLC ($8,379) |
| 2021 | $5,569 | 11 | US Retina LLC ($5,270) |
| 2020 | $2,828 | 10 | US Retina LLC ($2,601) |
| 2019 | $3,731 | 15 | US Retina LLC ($3,410) |
| 2018 | $362.90 | 18 | Allergan Inc. ($237.92) |
| 2017 | $210.13 | 11 | Allergan Inc. ($133.97) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: EYE CARE | ||||||
| 09/24/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Ophthalmology | ||||||
| 08/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: EYE CARE | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/20/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,323 | 17,808 | $3.3M | $1.3M |
| 2022 | 13 | 2,491 | 6,425 | $3.2M | $1.2M |
| 2021 | 14 | 2,410 | 6,635 | $3.2M | $1.3M |
| 2020 | 16 | 2,406 | 6,889 | $3.4M | $1.3M |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 139 | 970 | $1.2M | $664,234 | 57.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 49 | 12,060 | $523,800 | $349,094 | 66.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 299 | 1,173 | $879,750 | $98,355 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 498 | 685 | $166,160 | $56,061 | 33.7% |
| 92134 | Imaging of retina | Office | 2023 | 636 | 1,816 | $172,520 | $52,801 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 200 | 200 | $61,700 | $22,784 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 356 | $69,270 | $22,295 | 32.2% |
| J3590 | Unclassified biologics | Office | 2023 | 145 | 421 | $129,000 | $20,327 | 15.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 12 | 12 | $45,000 | $10,505 | 23.3% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 11 | 11 | $41,250 | $9,632 | 23.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $12,764 | $5,141 | 40.3% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 14 | 19 | $28,500 | $4,766 | 16.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 11 | 11 | $16,500 | $2,024 | 12.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $1,980 | $1,495 | 75.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 15 | 16 | $4,640 | $1,352 | 29.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 12 | $1,920 | $405.79 | 21.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 151 | 1,210 | $1.5M | $856,861 | 59.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 310 | 1,259 | $944,250 | $105,985 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 576 | 765 | $149,175 | $62,585 | 42.0% |
| 92134 | Imaging of retina | Office | 2022 | 713 | 1,948 | $185,060 | $57,455 | 31.0% |
| J3590 | Unclassified biologics | Office | 2022 | 175 | 546 | $199,000 | $49,156 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 223 | 223 | $55,750 | $25,081 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 365 | $54,750 | $23,097 | 42.2% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 18 | 18 | $67,500 | $15,816 | 23.4% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 11 | 12 | $30,000 | $8,276 | 27.6% |
About Dr. Lisa Borkowski, MD
Dr. Lisa Borkowski, MD is a Ophthalmology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033104435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Borkowski, MD has received a total of $24,461 in payments from pharmaceutical and medical device companies, with $1,776 received in 2024. These payments were reported across 163 transactions from 18 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($19,661).
As a Medicare-enrolled provider, Borkowski has provided services to 9,630 Medicare beneficiaries, totaling 37,757 services with total Medicare billing of $5.2M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Columbus, OH
- Active Since 09/13/2005
- Last Updated 11/20/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1033104435
Products in Payments
- EYLEA (Biological) $858.18
- OZURDEX (Drug) $702.69
- YUTIQ (Drug) $685.60
- Vabysmo (Drug) $545.56
- EYLEA HD (Biological) $516.74
- Izervay (Drug) $273.93
- ILUVIEN (Drug) $195.91
- Syfovre (Drug) $164.29
- Lucentis (Biological) $150.01
- BEOVU (Drug) $91.36
- Iluvien (Drug) $67.20
- DUREZOL (Drug) $52.15
- EYLEA AFLIBERCEPT INJECTION (Biological) $45.94
- XIPERE (Drug) $38.51
- PURIFIED CORTROPHIN GEL (Drug) $29.97
- PanOptix (Device) $25.74
- VABYSMO (Drug) $24.01
- Cimerli (Biological) $22.56
- ForeseeHome (Device) $16.40
- UPLIZNA (Drug) $16.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Columbus
Alice Epitropoulos, M.d, M.D
Ophthalmology — Payments: $611,779
Steven Katz, Md, MD
Ophthalmology — Payments: $202,492
Stephen Beaty, M.d, M.D
Ophthalmology — Payments: $36,455
Raymond Cho, Md, MD
Ophthalmology — Payments: $23,167
Bret Crumpton, D.o, D.O
Ophthalmology — Payments: $12,382
Richard Golden, Md, MD
Ophthalmology — Payments: $11,298